<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">35002947</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>01</Month>
        <Day>11</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Print">1664-2295</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>12</Volume>
            <PubDate>
              <Year>2021</Year>
            </PubDate>
          </JournalIssue>
          <Title>Frontiers in neurology</Title>
          <ISOAbbreviation>Front Neurol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Case Report: Takotsubo Cardiomyopathy in Bickerstaff Brainstem Encephalitis Triggered by COVID-19.</ArticleTitle>
        <Pagination>
          <StartPage>822247</StartPage>
          <MedlinePgn>822247</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">822247</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.3389/fneur.2021.822247</ELocationID>
        <Abstract>
          <AbstractText>Takotsubo cardiomyopathy (TCM) is a stress-induced cardiomyopathy triggered by critical illness including severe neurological disorders. However, an association between TCM and Bickerstaff brainstem encephalitis (BBE) has rarely been described. During the current coronavirus disease 2019 (COVID-19) pandemic, growing evidence indicates that COVID-19 often leads to various neurological disorders, but there are few reports of an association between COVID-19 and BBE. Here we report a case of TCM associated with BBE triggered by COVID-19, which subsided with immunotherapy for BBE. Both transthoracic echocardiography and electrocardiography led to early and accurate diagnosis of TCM. Sustained hemodynamic instability due to TCM was immediately lessened with immunotherapy whereas additional plasmapheresis and immunotherapy were required to treat BBE. This case indicates that BBE might follow COVID-19 and TCM should be considered when hemodynamic status remains unstable in a patient with BBE.</AbstractText>
          <CopyrightInformation>Copyright © 2021 Kimura, Hashiguchi, Tanaka, Hagiwara, Takahashi, Miyaji, Joki, Doi, Koga, Takeuchi and Tanaka.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Kimura</LastName>
            <ForeName>Mizuki</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hashiguchi</LastName>
            <ForeName>Shunta</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tanaka</LastName>
            <ForeName>Kenichi</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hagiwara</LastName>
            <ForeName>Manato</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Takahashi</LastName>
            <ForeName>Keita</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Miyaji</LastName>
            <ForeName>Yosuke</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Joki</LastName>
            <ForeName>Hideto</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Doi</LastName>
            <ForeName>Hiroshi</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Koga</LastName>
            <ForeName>Michiaki</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology and Clinical Neuroscience, Yamaguchi University Graduate School of Medicine, Ube, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Takeuchi</LastName>
            <ForeName>Hideyuki</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tanaka</LastName>
            <ForeName>Fumiaki</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>24</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Front Neurol</MedlineTA>
        <NlmUniqueID>101546899</NlmUniqueID>
        <ISSNLinking>1664-2295</ISSNLinking>
      </MedlineJournalInfo>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Bickerstaff brainstem encephalitis</Keyword>
        <Keyword MajorTopicYN="N">Takotsubo cardiomyopathy</Keyword>
        <Keyword MajorTopicYN="N">anti-GQ1b ganglioside antibody</Keyword>
        <Keyword MajorTopicYN="N">coronavirus disease 2019</Keyword>
        <Keyword MajorTopicYN="N">hemodynamic instability</Keyword>
        <Keyword MajorTopicYN="N">intravenous immunoglobulin therapy</Keyword>
        <Keyword MajorTopicYN="N">transthoracic echocardiogram</Keyword>
      </KeywordList>
      <CoiStatement>HT is an Associate Editor of Frontiers in Neurology and Frontiers in Immunology. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>25</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>8</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>10</Day>
          <Hour>9</Hour>
          <Minute>10</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>11</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>11</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35002947</ArticleId>
        <ArticleId IdType="pmc">PMC8741194</ArticleId>
        <ArticleId IdType="doi">10.3389/fneur.2021.822247</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Berger JR. COVID-19 and the nervous system. J Neurovirol. (2020) 26:143–8. 10.1007/s13365-020-00840-5</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s13365-020-00840-5</ArticleId>
            <ArticleId IdType="pmc">PMC7245181</ArticleId>
            <ArticleId IdType="pubmed">32447630</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Toscano G, Palmerini F, Ravaglia S, Ruiz L, Invernizzi P, Cuzzoni MG, et al. . Guillain-Barre syndrome associated with SARS-CoV-2. N Engl J Med. (2020) 382:2574–6. 10.1056/NEJMc2009191</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMc2009191</ArticleId>
            <ArticleId IdType="pmc">PMC7182017</ArticleId>
            <ArticleId IdType="pubmed">32302082</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li Z, Li X, Shen J, Chan MTV, Wu KWK. Miller fisher syndrome associated with COVID-19: an up-to-date systematic review. Environ Sci Pollut Res Int. (2021) 28:20939–44. 10.1007/s11356-021-13233-w</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11356-021-13233-w</ArticleId>
            <ArticleId IdType="pmc">PMC7936860</ArticleId>
            <ArticleId IdType="pubmed">33677662</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu Y, Xu X, Chen Z, Duan J, Hashimoto K, Yang L, et al. . Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun. (2020) 87:18–22. 10.1016/j.bbi.2020.03.031</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbi.2020.03.031</ArticleId>
            <ArticleId IdType="pmc">PMC7146689</ArticleId>
            <ArticleId IdType="pubmed">32240762</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Koga M, Kusunoki S, Kaida K, Uehara R, Nakamura Y, Kohriyama T, et al. . Nationwide survey of patients in Japan with bickerstaff brainstem encephalitis: epidemiological and clinical characteristics. J Neurol Neurosurg Psychiatry. (2012) 83:1210–5. 10.1136/jnnp-2012-303060</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/jnnp-2012-303060</ArticleId>
            <ArticleId IdType="pubmed">22851608</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yuki N, Sato S, Tsuji S, Hozumi I, Miyatake T. An immunologic abnormality common to bickerstaff's brain stem encephalitis and fisher's syndrome. J Neurol Sci. (1993) 118:83–7. 10.1016/0022-510X(93)90250-3</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0022-510X(93)90250-3</ArticleId>
            <ArticleId IdType="pubmed">8229054</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Al-Din AN, Anderson M, Bickerstaff ER, Harvey I. Brainstem encephalitis and the syndrome of miller fisher: a clinical study. Brain. (1982) 105:481–95. 10.1093/brain/105.3.481</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/brain/105.3.481</ArticleId>
            <ArticleId IdType="pubmed">7104664</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Llorente Ayuso L, Torres Rubio P, Beijinho do Rosario RF, Giganto Arroyo ML, Sierra-Hidalgo F. Bickerstaff encephalitis after COVID-19. J Neurol. (2021) 268:2035–37. 10.1007/s00415-020-10201-1</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00415-020-10201-1</ArticleId>
            <ArticleId IdType="pmc">PMC7471525</ArticleId>
            <ArticleId IdType="pubmed">32880723</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yalta K, Yilmaztepe M, Zorkun C. Left ventricular dysfunction in the setting of takotsubo cardiomyopathy: a review of clinical patterns and practical implications. Card Fail Rev. (2018) 4:14–20. 10.15420/cfr.2018:24:2</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.15420/cfr.2018:24:2</ArticleId>
            <ArticleId IdType="pmc">PMC5971666</ArticleId>
            <ArticleId IdType="pubmed">29892470</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Szardien S, Mollmann H, Willmer M, Akashi YJ, Hamm CW, Nef MH. Mechanisms of stress (takotsubo) cardiomyopathy. Heart Fail Clin. (2013) 9:197–205. 10.1016/j.hfc.2012.12.012</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.hfc.2012.12.012</ArticleId>
            <ArticleId IdType="pubmed">23562120</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moady G, Atar S. Takotsubo syndrome during the COVID-19 pandemic, state-of -the- art review. CJC Open. (2021) 3:1249–56. 10.1016/j.cjco.2021.05.011</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cjco.2021.05.011</ArticleId>
            <ArticleId IdType="pmc">PMC8149464</ArticleId>
            <ArticleId IdType="pubmed">34056570</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Finsterer J, Wahbi K. CNS disease triggering takotsubo stress cardiomyopathy. Int J Cardiol. (2014) 177:322–9. 10.1016/j.ijcard.2014.08.101</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ijcard.2014.08.101</ArticleId>
            <ArticleId IdType="pubmed">25213573</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Martins RP, Barbarot N, Coquerel N, Baruteau AE, Kolev I, Verin M. Takotsubo cardiomyopathy associated with guillain-barre syndrome: a differential diagnosis from dysautonomia not to be missed. J Neurol Sci. (2010) 291:100–2. 10.1016/j.jns.2010.01.005</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jns.2010.01.005</ArticleId>
            <ArticleId IdType="pubmed">20117795</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Odaka M, Yuki N, Yamada M, Koga M, Takemi T, Hirata K, et al. . Bickerstaff's brainstem encephalitis: clinical features of 62 cases and a subgroup associated with guillain-barre syndrome. Brain. (2003) 126:2279–90. 10.1093/brain/awg233</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/brain/awg233</ArticleId>
            <ArticleId IdType="pubmed">12847079</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sriwastava S, Kataria S, Tandon M, Patel J, Patel R, Jowkar A, et al. . Guillain barre syndrome and its variants as a manifestation of COVID-19: a systematic review of case reports and case series. J Neurol Sci. (2021) 420:117263. 10.1016/j.jns.2020.117263</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jns.2020.117263</ArticleId>
            <ArticleId IdType="pmc">PMC7725056</ArticleId>
            <ArticleId IdType="pubmed">33321326</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Keddie S, Pakpoor J, Mousele C, Pipis M, Machado PM, Foster M, et al. . Epidemiological and cohort study finds no association between COVID-19 and guillain-barre syndrome. Brain. (2021) 144:682–93. 10.1093/brain/awaa433</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/brain/awaa433</ArticleId>
            <ArticleId IdType="pmc">PMC7799186</ArticleId>
            <ArticleId IdType="pubmed">33313649</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>See FH, Goh Y, Sia CH, Tan BY, Yeo LL, Vijayan J, et al. . A brain-heart interaction: bickerstaff's brainstem encephalitis with takotsubo cardiomyopathy. QJM. (2020) 114:204–5. 10.1093/qjmed/hcaa218</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/qjmed/hcaa218</ArticleId>
            <ArticleId IdType="pubmed">32642763</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nef HM, Mollmann H, Akashi YJ, Hamm WC. Mechanisms of stress (Takotsubo) cardiomyopathy. Nat Rev Cardiol. (2010) 7:187–93. 10.1038/nrcardio.2010.16</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrcardio.2010.16</ArticleId>
            <ArticleId IdType="pubmed">20195267</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yalta K, Taylan G, Yalta T, Yetkin E. Takotsubo cardiomyopathy in the setting of multiple sclerosis: a multifaceted phenomenon with important implications. Monaldi Arch Chest Dis. (2020) 90. 10.4081/monaldi.2020.1420</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4081/monaldi.2020.1420</ArticleId>
            <ArticleId IdType="pubmed">32724231</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yalta K, Yetkin E, Yalta T. Takotsubo cardiomyopathy: an obscure cause of emerging cardiovascular manifestations in the setting of bickerstaff's brainstem encephalitis. Neurol Sci. (2021) 42:1181–3. 10.1007/s10072-020-04749-z</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10072-020-04749-z</ArticleId>
            <ArticleId IdType="pubmed">32975674</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Giustino G, Croft LB, Oates CP, Rahman K, Lerakis S, Reddy VY, et al. . Takotsubo cardiomyopathy in COVID-19. J Am Coll Cardiol. (2020) 76:628–9. 10.1016/j.jacc.2020.05.068</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jacc.2020.05.068</ArticleId>
            <ArticleId IdType="pmc">PMC7279731</ArticleId>
            <ArticleId IdType="pubmed">32517962</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
